Fidelity Investments
MBRX icon

Fidelity Investments’s Moleculin Biotech MBRX Stock Holding History

Fidelity Investments’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– -$7 – 5665
2026
Q1 		– Hold
0
– – – 5383
2025
Q2 		– Hold
0
– -$33 – 5431
2025
Q1 		– Hold
0
– – – 5187
2023
Q4 		– Hold
0
– -$1 – 5565
2023
Q3 		– Hold
0
– – – 5259
2023
Q2 		– Hold
0
– – – 5351
2023
Q1 		– Hold
0
– – – 5235
2022
Q4 		– Hold
0
– – – 5318
2022
Q3 		– Hold
0
– – – 5288
2022
Q2 		– Hold
0
– – – 5176

Other funds holding MBRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $68.5B AUM 24.33% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return